Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1985-01-30
1989-09-12
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514826, A61K 3156
Patent
active
048660515
ABSTRACT:
Beclomethasone dipropionate in the form of its micronised monohydrate substantially free from water other than water of crystallisation. Pharmaceutical compositions containing the compound are also described. The compositions may be in the form of powder inhalation cartridges especially suitable for the treatment and/or prophylaxis of asthma.
REFERENCES:
patent: 4347236 (1982-08-01), Tanskanen
patent: 4364923 (1982-12-01), Cook et al.
patent: 4370322 (1983-01-01), Busse et al.
patent: 4391755 (1983-07-01), Wang et al.
Acta Crystallographica (1981), B.37, 383-387, W. L. Duax et al.
The Theory and Practice of Industrial Pharmacy, Leon Lachman, Herbet A. Liebermann and J. L. Karug, (1976), p. 279.
Hunt John H.
Padfield John M.
Glaxo Group Limited
Lipovsky Joseph A.
Robinson Douglas W.
LandOfFree
Micronised beclomethasone dipropionate monohydrate compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Micronised beclomethasone dipropionate monohydrate compositions , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Micronised beclomethasone dipropionate monohydrate compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-916371